ClinicalTrials.gg
CompletedNCT03982433Updated Dec 13, 2019Results posted

Internet-based Videoconferencing to Address Alcohol Use and Pain

An interventional study of Motivation and Cognitive Behavioral Management for Alcohol and Pain in Chronic Pain and Alcohol Use, Unspecified, sponsored by Boston University Charles River Campus. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-12-13.

Sponsored by Boston University Charles River Campus · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
8
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

This research seeks to develop a novel, integrated behavioral approach to reduce heavy drinking and chronic pain among patients in HIV-care delivered via internet-based videoconferencing. This first open trial pilot study seeks to recruit patients in the clinic through posted flyers, cards and physician referral.

Read the detailed description

This study seeks to develop an integrated, behavioral video telehealth approach to address pain and heavy alcohol use among patients living with HIV and determine its feasibility and acceptability. Through an open pilot trial, this phase of this project will deliver an integrated alcohol-pain behavioral intervention to people living with HIV/AIDS (PLWHA) through videoconferencing. Intervention evaluation outcomes for this initial phase will include reduction of standard number of drinks per week, reduction in heavy drinking days, reduction of chronic pain severity and interference, ratings of patient satisfaction with treatment, and rate of treatment adherence.

02

Conditions studied

  • Chronic Pain
  • Alcohol Use, Unspecified

Keywords

  • HIV
03

In context

Chronic Pain

2,998 studies on the registry are indexed under Chronic Pain; 706 are open to participants now.

This study's enrollment of 8 is below the median of 60 across 2,209 interventional studies indexed under Chronic Pain.

Browse Chronic Pain studies →

Lead sponsor

Boston University Charles River Campus is the lead sponsor of 156 studies on the registry; 30 are open to participants now.

Of its 14 completed or terminated interventional studies of FDA-regulated products, 9 (64%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • engaged in HIV care, heavy drinking by more than 7/14 drinks per week (women/men) or by single episode of 4/5 (women/men), chronic (at least 3 months duration) moderate or greater (4 or more on the severity scale of the Brief Pain Inventory (BPI) non-cancer related pain.

Exclusion criteria

Exclusion Criteria:

  • psychoactive medication for pain or alcohol use for few than 2 months
  • history of bipolar disorder, schizophrenia, other psychotic disorder
  • current suicidal intent
  • prior history of alcohol withdrawal related seizures or delirium tremens
  • current behavioral treatment for pain or alcohol use
  • any scheduled surgery within next 6 months or acute life-threatening illness that requires treatment
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
8 participants (actual)

Study arms

  • Experimental
    Intervention

    participants all receive the intervention

    Behavioral: Motivation and Cognitive Behavioral Management for Alcohol and Pain

Interventions

  • BehavioralMotivation and Cognitive Behavioral Management for Alcohol and Pain

    Behavioral intervention that includes motivational, cognitive, and behavioral intervention strategies to reduce heavy drinking and chronic pain interference

06

What researchers measure

Primary outcomes

  1. Brief Pain Inventory Pain Severity

    BPI consists of 11-point scale items that reflect pain severity and pain interference Average pain severity in the past 7-days is measures with a single 11-point scale where "0" is best and "10" is worst. Pain interference is measures as the mean of 7-items, each also rated on a 11-point scale where "0" is best and "10 is worst" Scales range from 0 - 10

    Time frame: past 7 days

  2. Brief Pain Inventory Pain Interference

    BPI consists of 11-point scale items that reflect pain severity and pain interference Pain interference is measured as the mean of 7-items, each rated on a 11-point scale where "0" is best and "10 is worst" Scales range from 0 - 10

    Time frame: past 7 days

  3. Alcohol Time Line Follow Back...Heavy Drinking Episodes

    number of heavy drinking episodes in the past 30 days

    Time frame: past 30 days

  4. Alcohol Time Line Follow Back...Average Drinks Per Week

    average number of drinks per week in the past 30 days (total number of drinks 30 days/4.28)

    Time frame: past 30 days

  5. Client Satisfaction Questionnaire-8 [Modified]

    Evaluative ratings of the intervention received. Eight Likert-scale items regarding different components of treatment satisfaction are rated from 1-4. Some items are reversed scored and then they are summed so that higher scores reflect higher satisfaction with treatment. The possible range of scores is 8-32.

    Time frame: past 30 days

  6. Perceptions of Treatment Questionnaire

    Participants were asked about their experiences with different facets of the intervention using items that were scored from 0 - 8 with higher scores reflecting greater satisfaction with the treatment components.

    Time frame: past 30 days

Secondary outcomes

  1. Goal Systems Assessment Battery-Pain

    Ratings self-regulatory capacities related to pain. Participants rate their perceived self-regulatory skills related to pain management using 5-point Likert scale items. There are 4 subscales for each of the dimensions of self-regulation assessed; planning, monitoring, self-efficacy, and value about the behavior change goal. A mean scale score is taken for each subscale. The range for each subscale is 0-4. Higher scores reflect better outcomes.

    Time frame: past 30 days

  2. Goal Systems Assessment Battery-Alcohol

    Ratings self-regulatory capacities related to moderating alcohol use. Participants rate their perceived self-regulatory skills related to pain management using 5-point Likert scale items. There are 4 subscales for each of the dimensions of self-regulation assessed; planning, monitoring, self-efficacy, and value about the behavior change goal. A mean scale score is taken for each subscale. The range for each subscale is 0-4. Higher scores reflect better outcomes.

    Time frame: past 30 days

07

Results

Posted Dec 13, 2019

Participant flow

Recruited from medical clinic and ongoing cohort

Participant flow — Overall Study
MilestoneIntervention
Started8
Completed7
Not completed1
Withdrew: Lost to follow-up1

Outcome measures

PrimaryBrief Pain Inventory Pain Severity

BPI consists of 11-point scale items that reflect pain severity and pain interference Average pain severity in the past 7-days is measures with a single 11-point scale where "0" is best and "10" is worst. Pain interference is measures as the mean of 7-items, each also rated on a 11-point scale where "0" is best and "10 is worst" Scales range from 0 - 10

Time frame:
past 7 days
Reported as:
Median · units on a scale
Brief Pain Inventory Pain Severity
units on a scaleIntervention
Brief Pain Inventory Pain Severity5.0 ± 2.58
PrimaryBrief Pain Inventory Pain Interference

BPI consists of 11-point scale items that reflect pain severity and pain interference Pain interference is measured as the mean of 7-items, each rated on a 11-point scale where "0" is best and "10 is worst" Scales range from 0 - 10

Time frame:
past 7 days
Reported as:
Median · units on a scale
Brief Pain Inventory Pain Interference
units on a scaleIntervention
Brief Pain Inventory Pain Interference2.43 ± 2.68
PrimaryAlcohol Time Line Follow Back...Heavy Drinking Episodes

number of heavy drinking episodes in the past 30 days

Time frame:
past 30 days
Reported as:
Median · number of episodes
Alcohol Time Line Follow Back...Heavy Drinking Episodes
number of episodesIntervention
Alcohol Time Line Follow Back...Heavy Drinking Episodes2.0 ± 4.34
PrimaryAlcohol Time Line Follow Back...Average Drinks Per Week

average number of drinks per week in the past 30 days (total number of drinks 30 days/4.28)

Time frame:
past 30 days
Reported as:
Median · drinks/week
Alcohol Time Line Follow Back...Average Drinks Per Week
drinks/weekIntervention
Alcohol Time Line Follow Back...Average Drinks Per Week13 ± 21.57
PrimaryClient Satisfaction Questionnaire-8 [Modified]

Evaluative ratings of the intervention received. Eight Likert-scale items regarding different components of treatment satisfaction are rated from 1-4. Some items are reversed scored and then they are summed so that higher scores reflect higher satisfaction with treatment. The possible range of scores is 8-32.

Time frame:
past 30 days
Reported as:
Mean · units on a scale
Client Satisfaction Questionnaire-8 [Modified]
units on a scaleIntervention
Client Satisfaction Questionnaire-8 [Modified]29.29 ± 2.29
PrimaryPerceptions of Treatment Questionnaire

Participants were asked about their experiences with different facets of the intervention using items that were scored from 0 - 8 with higher scores reflecting greater satisfaction with the treatment components.

Time frame:
past 30 days
Reported as:
Mean · units on a scale
Perceptions of Treatment Questionnaire
units on a scaleIntervention
Perceptions of Treatment Questionnaire7.04 ± 1.15
SecondaryGoal Systems Assessment Battery-Pain

Ratings self-regulatory capacities related to pain. Participants rate their perceived self-regulatory skills related to pain management using 5-point Likert scale items. There are 4 subscales for each of the dimensions of self-regulation assessed; planning, monitoring, self-efficacy, and value about the behavior change goal. A mean scale score is taken for each subscale. The range for each subscale is 0-4. Higher scores reflect better outcomes.

Time frame:
past 30 days
Reported as:
Median · score on a scale
Goal Systems Assessment Battery-Pain
score on a scaleIntervention
Pain-Value3.25 ± 0.70
Pain-Self-efficacy3.0 ± 0.84
Pain-Monitoring3.0 ± 0.92
Pain-Planning2.75 ± 0.89
SecondaryGoal Systems Assessment Battery-Alcohol

Ratings self-regulatory capacities related to moderating alcohol use. Participants rate their perceived self-regulatory skills related to pain management using 5-point Likert scale items. There are 4 subscales for each of the dimensions of self-regulation assessed; planning, monitoring, self-efficacy, and value about the behavior change goal. A mean scale score is taken for each subscale. The range for each subscale is 0-4. Higher scores reflect better outcomes.

Time frame:
past 30 days
Reported as:
Median · units on a scale
Goal Systems Assessment Battery-Alcohol
units on a scaleIntervention
Alcohol-Value3.0 ± 0.87
Alcohol-Self-efficacy3.0 ± 0.71
Alcohol-Monitoring2.75 ± 0.82
Alcohol-Planning2.75 ± 0.89

Adverse events

Collected over 8 weeks. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Intervention0/8 (0%)0/8 (0%)0/8 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Intervention
Mean53.3 ± 8.83
Sex: Female, Male
Sex: Female, Male(Participants)Intervention
Female1
Male7
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Intervention
American Indian or Alaska Native0
Asian0
Native Hawaiian or Other Pacific Islander0
Black or African American6
White2
More than one race0
Unknown or Not Reported0
Region of Enrollment
Region of Enrollment(participants)Intervention
United States8
Brief Pain Inventory (BPI)
Brief Pain Inventory (BPI)(units on a scale)Intervention
pain severity5.5 ± 1.52
pain interference4.5 ± 2.24
Heavy Drinking Episodes
Heavy Drinking Episodes(episodes)Intervention
Median5.5 ± 5.62
Drinks/week from Timeline FollowBack
Drinks/week from Timeline FollowBack(drinks/week)Intervention
Median36.50 ± 18.43
08

Study locations

1 site
  • General Clinical Research Unit, Boston University
    Boston, Massachusetts 02215, United States
09

References and documents

Publications

  • Palfai TP, Kratzer MPL, Taylor JL, Otis JD, Winter MR. Addressing Pain and Heavy Drinking among Patients in HIV-Care: A Pilot Study of an Integrated Telehealth Intervention. AIDS Behav. 2025 Jun;29(6):1930-1943. doi: 10.1007/s10461-025-04660-8. Epub 2025 Feb 25. PubMed 39998790 ↗

Study documents

  • Protocol and statistical analysis plan · Sep 26, 2019

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2019 to primary completion in Jun 2019, 3 months.

Results were first posted in Dec 2019, 5 months after primary completion.

Of 1,209 non-industry interventional studies with no phase under Chronic Pain, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 39. This study's 3 months is below that.

Counting every sponsor, half of 1,296 studies reached it within 21 months; a quarter within 9 and three quarters within 39.

How these figures are worked out, and which studies are left out of them.

Registered
May 14, 2019
First posted
Jun 11, 2019
StartActual
Mar 1, 2019
Primary completionActual
Jun 27, 2019
CompletionActual
Jun 27, 2019
Results first posted
Dec 13, 2019
Last update
Dec 13, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 13, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03982433
Responsible party
Sponsor
First posted
Jun 11, 2019
Start date
Mar 1, 2019
Primary completion
Jun 27, 2019
Completion
Jun 27, 2019
Results posted
Dec 13, 2019
Last update
Dec 13, 2019

Study contacts

Tibor P Palfai, PhD
principal investigator · Boston University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion